Adicet Bio, Inc. (ACET)
4.57
-0.57
(-11.09%)
USD |
NASDAQ |
Oct 16, 16:00
4.60
+0.03
(+0.66%)
After-Hours: 20:00
Adicet Bio EPS Diluted (Quarterly) : -1.988 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.988 |
| March 31, 2026 | -1.884 |
| December 31, 2025 | -2.944 |
| September 30, 2025 | -4.717 |
| June 30, 2025 | -5.484 |
| March 31, 2025 | -0.3098 |
| December 31, 2024 | -5.060 |
| September 30, 2024 | -0.3355 |
| June 30, 2024 | -0.3299 |
| March 31, 2024 | -0.3543 |
| December 31, 2023 | -0.6852 |
| September 30, 2023 | -1.161 |
| June 30, 2023 | -0.7543 |
| March 31, 2023 | -0.7189 |
| December 31, 2022 | -0.7173 |
| September 30, 2022 | -0.5282 |
| June 30, 2022 | -0.5624 |
| March 31, 2022 | 0.1005 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.4663 |
| September 30, 2021 | -0.4396 |
| June 30, 2021 | -0.3411 |
| March 31, 2021 | -0.8168 |
| December 31, 2020 | -0.4566 |
| September 30, 2020 | -2.837 |
| June 30, 2020 | -62.14 |
| March 31, 2020 | -232.24 |
| December 31, 2019 | -48.84 |
| September 30, 2019 | -110.82 |
| June 30, 2019 | -3.596 |
| March 31, 2019 | -2.670 |
| December 31, 2018 | -1.437 |
| September 30, 2018 | -2.098 |
| June 30, 2018 | -3.36 |
| March 31, 2018 | -3.206 |
| December 31, 2017 | -92.06 |
| September 30, 2017 | -0.8261 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.36M |
| Total Expenses (Quarterly) | 21.36M |
| Enterprise Value | -62.55M |
| Earnings Yield | -252.4% |
| Normalized Earnings Yield | -252.36 |